CUMYL-PICA
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
1-pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1400742-32-6 |
PubChem | CID: 86273678 |
ChemSpider | 34450887 |
Chemical data | |
Formula | C23H28N2O |
Molecular mass | 348.49 g/mol |
|
|
|
CUMYL-PICA (SGT-56) is an indole-3-carboxamide based synthetic cannabinoid. It is the α,α-dimethylbenzyl analogue of SDB-006.[1] It was briefly sold in New Zealand during 2013 as an ingredient of at the time legal synthetic cannabis products, but the product containing CUMYL-BICA and CUMYL-PICA was denied an interim licensing approval under the Psychoactive Substances regulatory scheme, due to reports of adverse events in consumers.[2] CUMYL-PICA acts as a potent agonist for the cannabinoid receptors, with approximately 20x selectivity for CB1, having an EC50 of 0.66nM for human CB1 receptors and 13nM for human CB2 receptors.[3]
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ The Risk Assessment Score Table. New Zealand Ministry of Health, 27 September 2013
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Articles containing unverified chemical infoboxes
- Indoles
- Cannabinoids
- Designer drugs
- Indolecarboxamides
- Cannabinoid stubs